Download PDF
Dtsch Med Wochenschr 2017; 142(01): 32-40
DOI: 10.1055/s-0042-109659
Dossier
© Georg Thieme Verlag KG Stuttgart · New York

Infektiologische Differenzialdiagnosen bei granulomatösen Lungenerkrankungen

Infectious Causes of Granulomatous Lung Diseases
Daniel Grund
,
Caroline Isner
,
Bettina Temmesfeld-Wollbrück
,
Norbert Suttorp
,
Martin Witzenrath
Further Information

Publication History

Publication Date:
05 January 2017 (online)

Also available at
    Permissions and Reprints

Abstract

Infections are the most common cause of granulomatous lung diseases. A variety of different pathogens can cause granuloma formation. The diagnosis requires consideration of endemic characteristics, patients’ predispositions as well as specific requirements for pathogen detection. The aim of this review is to give a short overview of the most important causative pathogens and facilitate the differential diagnostic approach of granulomatous lung diseases.

Infektionen sind die häufigste Ursache für granulomatöse Lungenerkrankungen. Eine Vielzahl unterschiedlicher Erreger kann eine Granulombildung verursachen. Endemische Besonderheiten, Prädispositionen seitens der Patienten und spezifische Anforderungen an den Erregernachweis müssen bei der Diagnostik beachtet werden. Der vorliegende Artikel gibt eine Übersicht über die wichtigsten Erreger und dient dem Kliniker als Wegweiser in der rationalen Anforderung mikrobiologischer und pathologischer Labordiagnostik.

Schlüsselwörter

Granulomatöse Lungenerkrankung - Lungengranulome - Pilzinfektionen - Mykobakteriosen -

Key words

Pulmonary Granulomatous Infections - Fungal Infections - Mycobacteriosis
 

  • Literatur

  • 1 Adams DO. The granulomatous inflammatory response. Am J Pathol 1976; 84: 164-192
    PubMedGoogle Scholar
  • 2 Pathologie online. Entzündung II. www.pathologie-online.de/allgemeine-pathologie/6-2/ (letzter Zugriff 14.11.2016)
    PubMedGoogle Scholar
  • 3 Eishi Y. Etiologic link between sarcoidosis and Propionibacterium acnes. Respir Investig 2013; 51: 56-68
    PubMedGoogle Scholar
  • 4 Nikkels AF. Debrus S. Delvenne P. et al. Viral glycoproteins in herpesviridae granulomas. Am J Dermatopathol 1994; 16: 588-592
    CrossrefPubMedGoogle Scholar
  • 5 Zumla A. James DG. Granulomatous infections: etiology and classification. Clin Infect Dis 1996; 23: 146-158
    CrossrefPubMedGoogle Scholar
  • 6 Sweeney TE. Braviak L. Tato CM. et al. Genome-wide expression for diagnosis of pulmonary tuberculosis: a multicohort analysis. Lancet Respir Med 2016; 4: 213-224
    CrossrefPubMedGoogle Scholar
  • 7 Hoflich C. Sabat R. Rosseau S. et al. Naturally occurring anti-IFN-gamma autoantibody and severe infections with Mycobacterium cheloneae and Burkholderia cocovenenans. Blood 2004; 103: 673-675
    CrossrefPubMedGoogle Scholar
  • 8 Thomson RM. Yew WW. When and how to treat pulmonary non-tuberculous mycobacterial diseases. Respirology 2009; 14: 12-26
    CrossrefPubMedGoogle Scholar
  • 9 Griffith DE. Aksamit T. Brown-Elliott BA. et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175: 367-416
    CrossrefPubMedGoogle Scholar
  • 10 LPSN List of prokaryotic names with standing in nomenclature. Genus Mycobacterium. http://www.bacterio.net/mycobacterium.html (letzter Zugriff 14.11.2016)
    PubMedGoogle Scholar
  • 11 Shelton BG. Flanders WD. Morris GK. Mycobacterium sp. as a possible cause of hypersensitivity pneumonitis in machine workers. Emerg Infect Dis 1999; 5: 270-273
    CrossrefPubMedGoogle Scholar
  • 12 Silva CA. Danelishvili L. McNamara M. et al. Interaction of Mycobacterium leprae with human airway epithelial cells. Infect Immun 2013; 81: 2645-2659
    CrossrefPubMedGoogle Scholar
  • 13 Garcia-Bellmunt L. Sibila O. Solanes I. Pulmonary nocardiosis in patients with COPD: characteristics and prognostic factors. Arch Bronconeumol 2012; 48: 280-285
    PubMedGoogle Scholar
  • 14 Shariff M. Gunasekaran J. Pulmonary Nocardiosis: Review of Cases and an Update. Can Respir J 2016; 2016: 7494202
    PubMedGoogle Scholar
  • 15 Robert Koch-Institut. Q-Fieber. Epidemiologisches Bulletin 37/2002 in der aktualisierte Fassung vom Mai 2012. https://www.rki.de/DE/Content/Infekt/EpidBull/Merkblaetter/Ratgeber_Q-Fieber.html
    PubMedGoogle Scholar
  • 16 Kim SJ. Lee JH. Lee ES. et al. A case of secondary syphilis presenting as multiple pulmonary nodules. Korean J Intern Med 2013; 28: 231-235
    CrossrefPubMedGoogle Scholar
  • 17 Olson AL. Gutman JA. Welsh CH. A 50-year-old man with skin lesions and multiple pulmonary nodules. Chest 2004; 125: 2322-2327
    CrossrefPubMedGoogle Scholar
  • 18 Smith JW. Laquer GL. Barnett CW. Gumma of the lung, proved by the demonstration of treponema pallidum. Am J Syph Gonorrhea Vener Dis 1950; 34: 383-389
    PubMedGoogle Scholar
  • 19 Kontoyiannis DP. Bodey GP. Invasive aspergillosis in 2002: an update. Eur J Clin Microbiol Infect Dis 2002; 21: 161-172
    CrossrefPubMedGoogle Scholar
  • 20 Adam O. Auperin A. Wilquin F. et al. Treatment with piperacillin-tazobactam and false-positive Aspergillus galactomannan antigen test results for patients with hematological malignancies. Clin Infect Dis 2004; 38: 917-920
    CrossrefPubMedGoogle Scholar
  • 21 Nucci M. Carlesse F. Cappellano P. et al. Earlier diagnosis of invasive fusariosis with Aspergillus serum galactomannan testing. PLoS One 2014; 9: e87784
    CrossrefPubMedGoogle Scholar
  • 22 Azar MM. Assi R. Relich RF. et al. Blastomycosis in Indiana: Clinical and Epidemiologic Patterns of Disease Gleaned from a Multicenter Retrospective Study. Chest 2015; 148: 1276-1284
    CrossrefPubMedGoogle Scholar
  • 23 Hage CA. Knox KS. Wheat LJ. Endemic mycoses: overlooked causes of community acquired pneumonia. Respir Med 2012; 106: 769-776
    CrossrefPubMedGoogle Scholar
  • 24 Davis MJ. Eastman AJ. Qiu Y. et al. Cryptococcus neoformans-induced macrophage lysosome damage crucially contributes to fungal virulence. J Immunol 2015; 194: 2219-2231
    CrossrefPubMedGoogle Scholar
  • 25 Hof H. Fungal pneumonias: do they exist?. Pneumologie 2013; 67: 509-512
    Article in Thieme ConnectPubMedGoogle Scholar
  • 26 de Oliveira A. Unnasch TR. Crothers K. et al. Performance of a molecular viability assay for the diagnosis of Pneumocystis pneumonia in HIV-infected patients. Diagn Microbiol Infect Dis 2007; 57: 169-176
    CrossrefPubMedGoogle Scholar
  • 27 Boelaert JR. de Locht M. Van Cutsem J. et al. Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies. J Clin Invest 1993; 91: 1979-1986
    CrossrefPubMedGoogle Scholar
  • 28 Ibrahim AS. Edwards Jr JE. Fu Y. et al. Deferiprone iron chelation as a novel therapy for experimental mucormycosis. J Antimicrob Chemother 2006; 58: 1070-1073
    CrossrefPubMedGoogle Scholar
  • 29 Hage CA. Davis TE. Fuller D. et al. Diagnosis of histoplasmosis by antigen detection in BAL fluid. Chest 2010; 137: 623-628
    CrossrefPubMedGoogle Scholar
  • 30 Gavilanes F. Fernandes CJ. Souza R. Pulmonary arterial hypertension in schistosomiasis. Curr Opin Pulm Med 2016; 22: 408-414
    PubMedGoogle Scholar
  • 31 Szenasi Z. Kovacs AH. Pampiglione S. et al. Human dirofilariosis in Hungary: an emerging zoonosis in central Europe. Wien Klin Wochenschr 2008; 120: 96-102
    CrossrefPubMedGoogle Scholar
  • 32 Oudni-M'rad M. Cabaret J. M'Rad S. et al. Genetic relationship between the Echinococcus granulosus sensu stricto cysts located in lung and liver of hosts. Infect Genet Evol 2016; 44: 356-360
    CrossrefPubMedGoogle Scholar
  • 33 Karaman A. Yalcin A. Alper F. Lung metastasis caused by an infection with Echinococcus alveolaris. Interact Cardiovasc Thorac Surg 2013; 16: 411-412
    CrossrefPubMedGoogle Scholar
  • 34 Theegarten D. Marra A. Diagnostik und Therapie der pulmonalen Echinokokkose. Pneumologie 2004; 58: VPPRS_20
    Article in Thieme ConnectPubMedGoogle Scholar